R508 A NEW NON-TOXIC DRUG TREATMENT THAT KILLS CANCER

Size: px
Start display at page:

Download "R508 A NEW NON-TOXIC DRUG TREATMENT THAT KILLS CANCER"

Transcription

1 WE NEED YOUR HELP TESTING R508 A NEW NON-TOXIC DRUG TREATMENT THAT KILLS CANCER WE NEED $25,000 FOR CURRENT TESTING OF THIS POWERFUL NEW CANCER TREATMENT

2 TABLE OF CONTENTS WHAT YOU NEED TO KNOW ABOUT R508 IN 90 SECONDS OR LESS.. 3 THE SCIENCE: R508 KILLS CANCER BY BLOCKING A PROTEIN THAT CANCER CELLS NEED TO SURVIVE R508 ELIMINATES CANCER IN MICE WITH NO TOXIC SIDE EFFECTS 5 R508 IS LIKELY TO KILL CANCER CELLS IN HUMANS. 6 LABORATORY TESTS: R508 IS HIGHLY EFFECTIVE AGAINST MELANOMA EVEN WITH A SINGLE DOSE 7 R508 IS HIGHLY EFFECTIVE AGAINST MANY TYPES OF CANCER... 8 THE NEXT STEP: TESTING R508 IN DOGS WITH CANCER TAX-DEDUCTIBLE DONATIONS.. 10 Page 2 of 10

3 WHAT YOU NEED TO KNOW ABOUT R508 IN 90 SECONDS OR LESS (science details on following pages) WHAT IS R508? R508 is a new drug that kills cancer by blocking a protein that cancer cells need to survive. R508 was developed after 25 years of meticulous research by Dr. Sanjay Awasthi. WHO IS DR. SANJAY AWASTHI? Sanjay Awasthi, MD, is a biochemist and cancer doctor at the prestigious City of Hope Beckman Research Institute. Dr. Awasthi s research is so important it s been cited over 8,000 times by other scientists. And Dr. Awasthi isn t just a dedicated scientist; he s a compassionate oncologist who s personally treated thousands of cancer patients. IS R508 TOXIC? No. R508 is not a chemo drug. It won t make you sick to your stomach and it won t cause your hair to fall out. WHAT TYPES OF CANCERS CAN R508 TREAT? R508 has completely eliminated melanoma and neuroblastoma as well as cancers of the prostate, lung, breast, colon, pancreas and kidney in laboratory mice. WHAT COMES NEXT? Our next step is to humanely test R508 on beloved pet dogs with deadly cancers. Of course we will conduct our potentially lifesaving pet trials at licensed veterinary hospitals, under the supervision of dedicated veterinarians, and with the last hope permission of their loving owners. Successful tests in dogs will save the lives of man s best friends and help advance R508 toward human trials that just might save you or a family member in the future. HOW YOU CAN HELP Thanks to many concerned supporters, we have received initial funds to get us to this fantastic scientific breakthrough, but we need your help. Just about everyone you know has someone in their family who has had, or is currently suffering with, some form of cancer. You can help stop this needless misery! With your donations to the amazing City of Hope Cancer Research Hospital, our continuing research has the possibility of stopping many of these deadly cancers in the very near future. Please make a contribution to help us raise $25,000. Every dollar counts. Page 3 of 10

4 R508 KILLS CANCER BY BLOCKING A PROTEIN THAT CANCER CELLS NEED TO SURVIVE R508 was designed by Dr. Awasthi based on his research of a cancer protein called Rlip (aka RLIP76 or RALBP1). 1 R508 is a highly-effective anticancer agent that kills cancer cells rather than just stopping their growth. R508 specifically blocks the formation of Rlip protein in cancer cells. As Rlip declines, cancer cells die. R508 has no adverse effects on normal cells, yet it very effectively kills all major types of cancers in mice. Cancer cell Cytoplasm Cancer cell CANCER CELLS Cytoplasm Nucleus Nucleus R508 Rlip RNA Ribosome Rlip RNA X Ribosome Rlip gene (DNA) Cancer Cell Survival Growth Metastasis Resistance to Treatment Rlip protein Rlip protein causes cancers to grow, metastasize and become resistant to treatment Rlip gene (DNA) Cancer Cell Death Rlip protein R508 blocks Rlip CANCER CELLS DIE R508 is nontoxic in mice and causes no negative side effects. Unlike most chemotherapy drugs which increase the risk of diabetes and hyperlipidemia, R508 reduces blood glucose, cholesterol and triglycerides in mice. 1 Sanjay Awasthi, Sharad S. Singhal, Yogesh C. Awasthi, Bryan Martin, Jung-Hee Woo, C. Casey Cunningham, and Arthur E. Frankel, RLIP76 and Cancer, Clinical Cancer Research (July 15, 2008); Rit Vatsyayan, Poorna Shandra Rao Lelsani, Sanjay Awasthi, Sharad S. Singhal, RLIP76: A versatile transporter and an emerging target for cancer therapy, Biochemical Pharmacology (June 15, 2010). Page 4 of 10

5 % surviving cancer free R508 ELIMINATES CANCER IN MICE WITH NO TOXIC SIDE EFFECTS R508 Treatment Eliminated Cancer in 100% of p53 Knockout Mice 100% 50% 0% All R508-treated mice survived All untreated mice died of cancer by 22 weeks time to death (weeks) RESULTS NEVER PREVIOUSLY ACHIEVED BY ANY TREATMENT untreated R508 treated R508-treated Untreated Whether or not we get cancer depends upon a very important gene called p53. It protects our DNA and prevents healthy cells from becoming cancer cells. The ability to suppress cancer has earned p53 the title, Guardian of the Genome. 2 R508 is so effective that it even stops cancer in mice that are completely missing the p53 gene (called p53 Knockout mice). These mice always get cancer by the age of six months because they have no p53 gene to protect them. Despite their genetic vulnerability, R508 keeps these mice cancer free with no toxic side effects. R508 development has been funded by the National Institutes of Health for the past 2 decades. The mechanism of action has been painstakingly demonstrated in over 100 scientific publications by Dr. Awasthi in high-impact journals. 2 Anna Mandinova and Sam Lee, Guardian of the Genome: p53 The Gene That Cracked the Cancer Code, Science Magazine (April 2015). Page 5 of 10

6 508 IS LIKELY TO STOP CANCER IN HUMANS Many cancer treatments are successful in mice, but fail when used on human cancer patients. Dr. Awasthi s research indicates that R508 is likely to work in humans because: R508 blocks the Rlip protein that cancer cells need to survive Rlip protein increases similarly in both mouse and human cancer cells Laboratory studies show nearly identical (98%) function of Rlip in cultured mouse cancer cells and cultured human cancer cells Cancer cell Cytoplasm Nucleus Rlip gene (DNA) Rlip RNA Ribosome Rlip protein The Rlip protein in mice and humans is structurally nearly identical. Cancer Cell Rlip protein causes cancers Survival to grow, metastasize and become Growth resistant to treatment Metastasis Resistance to Treatment Blocking Rlip with R508 should kill human cancer just as effectively as it kills cancer in mice. 3 3 Only clinical testing in human cancer patients can conclusively determine if R508 is an effective cancer treatment for humans. Page 6 of 10

7 R508 IS HIGHLY EFFECTIVE AGAINST MELANOMA EVEN WITH A SINGLE DOSE Before Treatment Tumors Grow Rapidly Without R508 Treatment After One Dose of R508 Tumors Shrink Rapidly After a Single Dose of R508 Time (days) Shown here is the striking efficacy of a single-dose treatment of R508 in a highly resistant animal malignancy model of the p53 knockout mouse Page 7 of 10

8 Melanoma Prostate Cancer Kidney Cancer Pancreatic Cancer Colon Cancer Breast Cancer Neuroblastoma Lung Cancer Percent Change in Cancer Size R508 IS HIGHLY EFFECTIVE AGAINST MANY TYPES OF CANCER RED: GREEN: UNTREATED MICE MICE TREATED WITH R % 200% Un-treated Treated with R508 After 30 days 100% Cancers in untreated mice increased by % In mice treated with R508, lung and colon cancers were 100% eliminated and other cancers decreased by an average of 89% 0% -100% After just 30 days, 8 types of cancers treated with R508 were either completely eliminated or nearly gone while untreated cancers continued to grow. Page 8 of 10

9 THE NEXT STEP: TESTING R508 IN DOGS WITH CANCER Pet dogs with cancer will be treated with R508 to provide further evidence that it can work in humans. Research supporting relationships between human and dog cancers continue to grow. We ve learned that the genetic alterations influencing cancer growth in humans is similar in dogs. 4 And scientists have shown that cancers in pet dogs and humans share many features, including appearance, biological behavior and, most importantly, response to treatments. 5 We will partner with highly-experienced veterinarians at licensed animal hospitals to humanely treat dogs with deadly cancers. Clinical trials in dogs are similar to those done in humans, with safety protections in place to minimize harm. 6 If we re successful, we ll save the lives of pets that otherwise would have died from cancer. We ll use this achievement to broaden the use of R508 and make the treatment widely available to veterinary clinics and, of course, to advance R508 closer to human trials. Pet dogs may be humans best friends in a new arena of life: cancer treatment, said University of Illinois veterinary clinical medicine professor Timothy Fan. Physiological similarities between dogs and humans, and conserved genetics between some dog and human cancers, can allow pet dogs to serve as useful models for studying new cancer drugs. 7 Veterinary clinical medicine professor Timothy Fan recently tested an anticancer drug in pet dogs with lymphoma and osteosarcoma. There is heterogeneity in the human population and in dogs. So I would argue that if your drug agent produces positive results in dogs, that would give me greater confidence that those findings would be translatable to people. 8 A successful test of R508 in dogs will save the lives of man s best friends and provide compelling evidence of its likely effectiveness in humans. 9 4 Melissa Paoloni and Chand Khanna, Comparative Oncology Today, Veterinary Clinic of North America: Small Animal Practice (November 2007). 5 Melissa Paoloni and Chand Khanna, Translation of new cancer treatments from pet dogs to humans, Nature Reviews Cancer (February 2008). 6 Human and canine lymphomas share molecular similarities, first large-scale comparison shows, UNC healthcare & UNC School of Medicine (June 2013). 7 Diana Yates, Drug trials in pet dogs with cancer may speed advances in human oncology, University of Illinois Life Sciences (June 16, 2015). 8 Ibid. 9 Only clinical testing in human cancer patients can conclusively determine if R508 is an effective cancer treatment for humans. Page 9 of 10

10 TAX-DEDUCTIBLE DONATIONS* Tax-deductible donations are payable to CITY OF HOPE. On the memo line of the check please write:. Send checks to: Philanthropy City of Hope Comprehensive Cancer Center 1500 E. Duarte Road Duarte, CA *City of Hope is a 501(c)3 not-for-profit charitable organization. EIN: CONTACT: Fred Powers Page 10 of 10

The Role of Gene Therapy in Cancer Treatment. Rehan Mujahid. Abstract

The Role of Gene Therapy in Cancer Treatment. Rehan Mujahid. Abstract The Role of Gene Therapy in Cancer Treatment Rehan Mujahid Abstract Cancer is one of the major diseases in the world. This paper explores the biology of cancer cells and explains how they are originated.

More information

Fact Sheet: Molecular Imaging and Cancer

Fact Sheet: Molecular Imaging and Cancer Fact Sheet: Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the American Cancer Society, an estimated 1.48 million new

More information

1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT

1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT 1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT Learning that your pet has a diagnosis of cancer can be overwhelming. We realize that your pet

More information

Biological Therapies for Cancer

Biological Therapies for Cancer Biological Therapies for Cancer Key Points Biological therapies use the body's immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Biological therapies

More information

Resumen Curricular de los Profesores. Jesse Boehm

Resumen Curricular de los Profesores. Jesse Boehm Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub

More information

Cancer Patients Urgently Need Effective, Genetically-Targeted Treatments

Cancer Patients Urgently Need Effective, Genetically-Targeted Treatments Cancer Patients Urgently Need Effective, Genetically-Targeted Treatments The Core Problem One Symptom, Not One Disease The disease we call cancer is the second most common cause of death in the United

More information

If you were diagnosed with cancer today, what would your chances of survival be?

If you were diagnosed with cancer today, what would your chances of survival be? Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However

More information

Cancer: DNA Synthesis, Mitosis, and Meiosis

Cancer: DNA Synthesis, Mitosis, and Meiosis Chapter 5 Cancer: DNA Synthesis, Mitosis, and Meiosis Copyright 2007 Pearson Copyright Prentice Hall, 2007 Inc. Pearson Prentice Hall, Inc. 1 What Is Cancer? Benign tumors do not invade surrounding tissue

More information

What Cancer Patients Need To Know

What Cancer Patients Need To Know Taking Part in Clinical Trials What Cancer Patients Need To Know NATIONAL INSTITUTES OF HEALTH National Cancer Institute Generous support for this publication was provided by Novartis Oncology. Taking

More information

What is Cancer? Pediatric Oncologist. What is Cancer? A doctor who takes care of kids with cancer

What is Cancer? Pediatric Oncologist. What is Cancer? A doctor who takes care of kids with cancer Public Education Seminar Community Outreach Program January 27th, 2010 What is Cancer? Introduced by Aubrey Van Kirk What is Cancer? Patrick Campbell, MD, PhD Department of Oncology St. Jude Children s

More information

MEDICAL BREAKTHROUGHS RESEARCH SUMMARY

MEDICAL BREAKTHROUGHS RESEARCH SUMMARY MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: Training the Body to Fight Melanoma REPORT: 3823 BACKGROUND: Melanoma is the most dangerous form of skin cancer that can be hard to treat and fatal if not

More information

Ending cancer. Together.

Ending cancer. Together. Ending cancer. Together. Making History by Being First To achieve something as big and bold as ending cancer requires the courage to be first and a willingness to partner with others. At the Robert W.

More information

Ask Us About Clinical Trials

Ask Us About Clinical Trials Ask Us About Clinical Trials Clinical Trials and You. Our specialists and researchers are at the forefront of their fields and are leading the way in developing new therapies and procedures for diagnosing

More information

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.

More information

A Career in Pediatric Hematology-Oncology? Think About It...

A Career in Pediatric Hematology-Oncology? Think About It... A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T

More information

Biologic Basis of Breast Cancer Treatment

Biologic Basis of Breast Cancer Treatment Biologic Basis of Breast Cancer Treatment Julie R. Gralow, M.D. Director, Breast Medical Oncology Jill Bennett Endowed Professor of Breast Cancer Professor, Global Health University of Washington School

More information

Metastatic Breast Cancer...

Metastatic Breast Cancer... DIAGNOSIS: Metastatic Breast Cancer... What Does It Mean For You? A diagnosis of metastatic breast cancer can be frightening. It raises many questions and reminds us of days past when cancer was such a

More information

Hemophilia Care. Will there always be new people in the world with hemophilia? Will hemophilia be treated more effectively and safely in the future?

Hemophilia Care. Will there always be new people in the world with hemophilia? Will hemophilia be treated more effectively and safely in the future? Future of This chapter provides answers to these questions: Will there always be new people in the world with hemophilia? Will hemophilia be treated more effectively and safely in the future? Will the

More information

Triple Negative Breast Cancer, 2014: Expert Perspectives

Triple Negative Breast Cancer, 2014: Expert Perspectives Triple Negative Breast Cancer, 2014: Expert Perspectives A Guide for Patients This guide is based on an expert panel discussion titled "Triple Negative Breast Cancer: Practical Treatment Strategies," developed

More information

Griffith University - Case for Support. Mesothelioma Research Program

Griffith University - Case for Support. Mesothelioma Research Program Griffith University - Case for Support Mesothelioma Research Program Professor Lyn Griffiths Director, Dean, Research and Director, Genomics Research Centre (GHI) Established in 2007. Integrated health

More information

Clinical Cancer Research: Alternative IRB Models and Enhancing Progress

Clinical Cancer Research: Alternative IRB Models and Enhancing Progress Clinical Cancer Research: Alternative IRB Models and Enhancing Progress Lowell E. Schnipper, M.D. Berenson Professor of Medicine Chief, Hematology-Oncology Beth Israel Deaconess Medical Dynamics of Clinical

More information

Do I really need critical illness cover? A guide to protect against the financial impact of a critical illness

Do I really need critical illness cover? A guide to protect against the financial impact of a critical illness Do I really need critical illness cover? A guide to protect against the financial impact of a critical illness What's inside 2 Cancer survival rates 5 Survival rates are improving 6 Coping with a critical

More information

Medical Marijuana in Oncology. Does MJ cure cancer?

Medical Marijuana in Oncology. Does MJ cure cancer? Medical Marijuana in Oncology J. Mark Sloan, MD Assistant Professor of Medicine Boston University Does MJ cure cancer? Suggestion from in vitro and animal studies that cannabinoids may impair growth of

More information

How Can Institutions Foster OMICS Research While Protecting Patients?

How Can Institutions Foster OMICS Research While Protecting Patients? IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice

More information

Metastatic Cancer: Questions and Answers. Key Points

Metastatic Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Metastatic Cancer: Questions

More information

RADIATION THERAPY FOR BRAIN METASTASES. Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY

RADIATION THERAPY FOR BRAIN METASTASES. Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY RADIATION THERAPY FOR BRAIN METASTASES Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT BRAIN METASTASIS Brain metastases are clusters

More information

METASTASES TO THE BONE

METASTASES TO THE BONE RADIATION THERAPY FOR METASTASES TO THE BONE Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY WHAT ARE BONE METASTASES? Cancer that starts

More information

PROSTATE CANCER. Straight Talk for African-American Men and Their Families

PROSTATE CANCER. Straight Talk for African-American Men and Their Families PROSTATE CANCER Straight Talk for African-American Men and Their Families No Man is Invincible There have been lots of ups and downs in my life s journey, but nothing to prepare me for those four echoing

More information

Biological Therapies for Cancer: Questions and Answers. Key Points

Biological Therapies for Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Biological Therapies for

More information

Funding world-class research We ve combined the long-term, expert programmes run from dedicated research centres and units funded by Breakthrough Breast Cancer with the wider geographical spread and rapid

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

Patient Support Guide

Patient Support Guide Patient Support Guide to genetic testing for hereditary breast and ovarian cancer syndrome Testing for BRCA1 and BRCA2 is available from Quest Diagnostics. Quest Diagnostics Patient Support Guide to Genetic

More information

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing These Are Hopeful Times for Lung Cancer Survivors When people first learn they have cancer, they are often afraid. But

More information

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD Gwen L. Nichols, M.D., is currently the Oncology Site Head of the Roche Translational Clinical Research Center at Hoffman- LaRoche. In this

More information

SUMMARY. Randolph Fillmore, Florida Science Communications

SUMMARY. Randolph Fillmore, Florida Science Communications SUMMARY Randolph Fillmore, Florida Science Communications The H. Lee Moffitt Cancer Center held its first Advanced Prostate Cancer Collaboration roundtable discussion November 24, 2008. The roundtable

More information

Osamu Mizukami,MD,PhD,DrPH Health Promotion Clinic, Tokyo

Osamu Mizukami,MD,PhD,DrPH Health Promotion Clinic, Tokyo Osamu Mizukami,MD,PhD,DrPH Health Promotion Clinic, Tokyo I am a doctor of internal medicine from Japan. I have my clinic located at the center of Tokyo. Ninety percent of my patients have all sites of

More information

Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer

Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer Your Certified Professional Cancer Coach An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer The CPCC Patient Program Nutrition & Lifestyle Oncology A Cancer Diagnosis

More information

Fundraising and Research Objectives

Fundraising and Research Objectives THE EHE FOUNDATION THE EHE RARE CANCER CHARITY (UK)* THE EHE RARE CANCER FOUNDATION (AUSTRALIA)* Fundraising and Research Objectives Thank you for taking the time to find and engage with our Fundraising

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

Pancreatic Cancer is the fourth leading cause of cancer death with the lowest

Pancreatic Cancer is the fourth leading cause of cancer death with the lowest Abstract Pancreatic Cancer is the fourth leading cause of cancer death with the lowest survivability. Usually by the time of diagnosis, the cancer has already spread throughout the body and there has not

More information

Benefits in oncology. Mechanism of action

Benefits in oncology. Mechanism of action Mechanism of action The word cancer refers to a number of different diseases that share a common trait: the rapid, unrestrained growth and spread of cells that can invade and destroy surrounding tissues,

More information

Molecular Imaging and Prostate Cancer

Molecular Imaging and Prostate Cancer Molecular Imaging and Prostate Cancer Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. Based on rates from 2004 2006, the National Cancer Institute

More information

immunotherapy a guide for the patient

immunotherapy a guide for the patient immunotherapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2 immunotherapy... 5 Monoclonal Antibodies... 6 Vaccines... 7 Adoptive T-Cell Transfer... 8 Oncolytic Viruses...

More information

New strategies in anticancer therapy

New strategies in anticancer therapy 癌 症 診 療 指 引 簡 介 及 臨 床 應 用 New strategies in anticancer therapy 中 山 醫 學 大 學 附 設 醫 院 腫 瘤 內 科 蔡 明 宏 醫 師 2014/3/29 Anti-Cancer Therapy Surgical Treatment Radiotherapy Chemotherapy Target Therapy Supportive

More information

Robert Bristow MD PhD FRCPC

Robert Bristow MD PhD FRCPC Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

Immune cells from healthy people pulverise cancer

Immune cells from healthy people pulverise cancer Published on ScienceNordic (http://sciencenordic.com) Home > Printer-friendly PDF > Printer-friendly PDF Immune cells from healthy people pulverise cancer Health[1] Health[1]Cancer research [2]immune system

More information

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions

More information

THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS

THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.

More information

Newsletter. WntResearch AB, Medeon Science Park, Per Albin Hanssons väg 41, 205 12 Malmö, Sweden. Primary Objective:

Newsletter. WntResearch AB, Medeon Science Park, Per Albin Hanssons väg 41, 205 12 Malmö, Sweden. Primary Objective: Newsletter This resume of the results from the phase 1 study with Foxy-5 is based on clinical and laboratory data from the study, and these data have now been locked into the database. The full report

More information

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending... CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and

More information

1in3 WHAT WE DO. Our vision is to bring forward the day when all cancers are cured.

1in3 WHAT WE DO. Our vision is to bring forward the day when all cancers are cured. cruk.org WHAT WE DO Our vision is to bring forward the day when all cancers are cured. Thousands of people are alive today thanks to research. Animal studies have played an important part in this progress.

More information

Level 1. Nutrition & Lifestyle Oncology Certificate

Level 1. Nutrition & Lifestyle Oncology Certificate Level 1 Nutrition & Lifestyle Oncology Certificate ONE MODULE 1 A Cancer Diagnosis Learn what cancer is; how/why it develops; diagnostic tests; inflammatory/ hormonal connections; 5 most important steps

More information

Clinical Trials: What You Need to Know

Clinical Trials: What You Need to Know Clinical Trials: What You Need to Know Clinical trials are studies in which people volunteer to test new drugs or devices. Doctors use clinical trials to learn whether a new treatment works and is safe

More information

Cancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.

Cancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada. Underwriting cancer In this issue of the Decision, we provide an overview of Canadian cancer statistics and the information we use to make an underwriting decision. The next few issues will deal with specific

More information

Clinical Trials and YOU

Clinical Trials and YOU Clinical Trials and YOU What are clinical trials? Controlled studies to determine how a particular anti-cancer strategy ( i.e. treatment ) affects the people who receive it Involve rigorous scientific

More information

19. Drug Treatment Trials

19. Drug Treatment Trials 1 9. D R U G T R E A T M E N T T R I A L S 19. Drug Treatment Trials The science behind the Progeria clinical drug trials Trial medications at a glance Progeria clinical drug trials The science behind

More information

California HealthCare Foundation Education materials for patients with advanced cancer

California HealthCare Foundation Education materials for patients with advanced cancer California HealthCare Foundation Education materials for patients with advanced cancer The California HealthCare Foundation (CHCF) commissioned research to explore options around the development of patient

More information

Fulfilling the Promise

Fulfilling the Promise Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,

More information

Starting treatment early with PERJETA

Starting treatment early with PERJETA Starting treatment early with PERJETA A TREATMENT FOR HER2-POSITIVE EARLY BREAST CANCER GIVEN BEFORE SURGERY HER2 = human epidermal growth factor receptor 2. What does PERJETA treat? PERJETA (pertuzumab)

More information

targeted therapy a guide for the patient

targeted therapy a guide for the patient targeted therapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2-3 Gene changes... 4-5 Testing... 7-8 Targeted therapy... 9-11 Drugs Targeting EGFR... 12 Drugs Targeting

More information

American Cancer Society Extramural Grants

American Cancer Society Extramural Grants Page: 1 Graduate Scholarships in Cancer Nursing Practice (GSCNP) GSCNP-14-118-01 Abbott, Linda, MSN MENTOR: Hooke, Mary C., PhD, RN School of Nursing Graduate Scholarship in Cancer Nursing Practice 07/01/2014

More information

Future Directions in Cancer Research What does is mean for medical physicists and AAPM?

Future Directions in Cancer Research What does is mean for medical physicists and AAPM? Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman

More information

Beyond Traditional Treatments for Lung Cancer: The Roles of Molecular Medicine and Individualized Therapies (Video Transcript)

Beyond Traditional Treatments for Lung Cancer: The Roles of Molecular Medicine and Individualized Therapies (Video Transcript) Beyond Traditional Treatments for Lung Cancer: The Roles of Molecular Medicine and Individualized Therapies (Video Transcript) To view the accompanying video of this transcript and to download a PDF of

More information

National Framework for Excellence in

National Framework for Excellence in National Framework for Excellence in Lung Cancer Screening and Continuum of Care declaration of purpose Rights and Expectations THE RIGHTS OF THE PEOPLE Lung cancer kills more Americans than the next four

More information

I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several

I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several Track 3: Goals of therapy I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several factors she ll use to decide what s best for me. Let s talk about making treatment

More information

Cancer: Genetic testing can save lives

Cancer: Genetic testing can save lives Cancer: Genetic testing can save lives Track chances of having a tumor's tendency among people with a history of disease cases in the family, but practice should not be trivialized and hurt even more who

More information

Watson in Healthcare. Thomas F. Anglero Innovation Director

Watson in Healthcare. Thomas F. Anglero Innovation Director Watson in Healthcare Thomas F. Anglero Innovation Director Thomas.Anglero@no.IBM.com 2015 International Business Machines Corporation - Nephrology Advisor 2 2015 International Business Machines Corporation

More information

Achievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for

Achievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for Achievements Report August 2015 CURING CANCER Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for cancer? Since cancer is complex and comes in many forms, its

More information

Expertise and Genuine Compassion Come Together

Expertise and Genuine Compassion Come Together Where World-Class Expertise Expertise and Genuine Compassion Come Together 0011000110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000 000010111000101110011000110100111100110111100000101010011000101100010111000010010000100010000100

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

RIGHT TREATMENT, RIGHT PATIENT RIGHT TIME!

RIGHT TREATMENT, RIGHT PATIENT RIGHT TIME! RIGHT TREATMENT, RIGHT PATIENT RIGHT TIME! Richard Kennedy MB BSc PhD FRCP McClay Professor in Medical Oncology Queen s University r.kennedy@qub.ac.uk Centre for Cancer Research & Cell Biology Outline

More information

leukemia, lymphoma and marrow or stem cell transplant survivors

leukemia, lymphoma and marrow or stem cell transplant survivors After treatment issues for leukemia, lymphoma and marrow or stem cell transplant survivors Lauren C Pinter Brown MD FACP Lauren C. Pinter-Brown MD, FACP Director, UCLA Lymphoma Program Clinical Professor

More information

16 MEDICINE AT MICHIGAN

16 MEDICINE AT MICHIGAN 16 MEDICINE AT MICHIGAN BELIEVING IN U-M RESEARCHERS WORK TO SHED LIGHT ON THE GRIM WORLD OF PANCREATIC CANCER BY SALLY POBOJEWSKI 17 WWW.MEDICINEATMICHIGAN.ORG/MAGAZINE 18 ancreatic cancer is a cruel

More information

What is a Stem Cell Transplantation?

What is a Stem Cell Transplantation? What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am

More information

IT S TIME FOR A SERIOUS DISCUSSION WITH YOUR ONCOLOGIST ABOUT THEIR CHEMOTHERAPY DOSING PLAN FOR YOU.

IT S TIME FOR A SERIOUS DISCUSSION WITH YOUR ONCOLOGIST ABOUT THEIR CHEMOTHERAPY DOSING PLAN FOR YOU. IT S TIME FOR A SERIOUS DISCUSSION WITH YOUR ONCOLOGIST ABOUT THEIR CHEMOTHERAPY DOSING PLAN FOR YOU. Since you ve found your way to this doctor discussion guide, you already know a lot. You know there

More information

A guide for the patient

A guide for the patient Understanding series LUNG CANCER CLINICAL TRIALS 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS The Basics What is a Clinical Trial?...3 Types of Clinical Trials... 3 Phases

More information

Cancer Genomics: What Does It Mean for You?

Cancer Genomics: What Does It Mean for You? Cancer Genomics: What Does It Mean for You? The Connection Between Cancer and DNA One person dies from cancer each minute in the United States. That s 1,500 deaths each day. As the population ages, this

More information

Monoclonal Antibody Therapy: Innovations in Cancer Treatment. James Choi ENGL 202C

Monoclonal Antibody Therapy: Innovations in Cancer Treatment. James Choi ENGL 202C Monoclonal Antibody Therapy: Innovations in Cancer Treatment James Choi ENGL 202C Treating Cancer with Monoclonal Antibody Therapy Researchers and scientists have been working for decades to find a cure

More information

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer

More information

The activity. (a) none (b) 100% /all of them (c) none

The activity. (a) none (b) 100% /all of them (c) none Teacher Notes Introduction This activity is based on an article explaining the genetics. Several activities are included on the student sheet to focus their engagement with the text. You may not wish to

More information

The Clinical Case for Individualized Use of Proton Beam Therapy

The Clinical Case for Individualized Use of Proton Beam Therapy The Clinical Case for Individualized Use of Proton Beam Therapy According to physicians and researchers who use proton beam therapy, the technology is a long-needed, excellent alternative to use of conventional

More information

Adjuvant Therapy for Breast Cancer: Questions and Answers

Adjuvant Therapy for Breast Cancer: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast

More information

The Basic Biological Effects of Ionizing Radiation on the Cell and its Genetic Material

The Basic Biological Effects of Ionizing Radiation on the Cell and its Genetic Material The Basic Biological Effects of Ionizing Radiation on the Cell and its Genetic Material PRESENTED BY: Martin L. Meltz, Ph.D. Chief, Radiobiology Group, Department of Radiation Oncology, and Director, Center

More information

Human Genome Organization: An Update. Genome Organization: An Update

Human Genome Organization: An Update. Genome Organization: An Update Human Genome Organization: An Update Genome Organization: An Update Highlights of Human Genome Project Timetable Proposed in 1990 as 3 billion dollar joint venture between DOE and NIH with 15 year completion

More information

Biofocus Molecular Diagnostic Panel

Biofocus Molecular Diagnostic Panel Biofocus Molecular Diagnostic Panel Dr. Lothar Prix Biofocus GmbH, Recklinghausen, Germany www.biofocus.de Molecular detection of infectious diseases Human & veterinary hereditary diseases / genetic predisposition

More information

The Impact of the Ted Mullin Fund at the University of Chicago Medicine. February 2015

The Impact of the Ted Mullin Fund at the University of Chicago Medicine. February 2015 The Impact of the Ted Mullin Fund at the University of Chicago Medicine February 2015 Thanks to the dedication of the Ted Mullin Fund supporters over the past eight years, University of Chicago Medicine

More information

Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org

Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA

More information

OVARIAN CANCER 101 7/16/14 FAST FACTS

OVARIAN CANCER 101 7/16/14 FAST FACTS OVARIAN CANCER 101 Victoria L Chiou, MD Women s Malignancies Branch National Cancer Institute, National Institutes of Health July 11, 2014 FAST FACTS Approximately 22,000 women will be diagnosed with ovarian

More information

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Update in Hematology Oncology Targeted Therapies. Mark Holguin Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning

More information

The Clinical Trials Process an educated patient s guide

The Clinical Trials Process an educated patient s guide The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-

More information

Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program

Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program Introduction: Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and

More information

Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision

Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort

More information

CHAPTER 2: UNDERSTANDING CANCER

CHAPTER 2: UNDERSTANDING CANCER CHAPTER 2: UNDERSTANDING CANCER INTRODUCTION We are witnessing an era of great discovery in the field of cancer research. New insights into the causes and development of cancer are emerging. These discoveries

More information

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved microrna 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions of target mrnas Act as negative

More information

Chinese Herbal Medicine

Chinese Herbal Medicine Chinese Herbal Medicine Guest Expert: Yung-chi, MD Henry Bronson Professor of Pharmacology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Dr. Ed and Ken. I am Bruce Barber.

More information

Doctor Discussion Guide

Doctor Discussion Guide Talking to your healthcare provider about LONSURF (trifluridine and tipiracil) If you have colon or rectal cancer that has spread to other parts of your body and have previously been treated with or cannot

More information

Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities

Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities Vincent A. Miller, M.D. Foundation Medicine, Inc. AACR Annual Meeting 2012 Current Concepts session

More information

incidence rates of other cancers. The word mesothelioma is derived from the English word

incidence rates of other cancers. The word mesothelioma is derived from the English word Mesothelioma is a devastating form of cancer that is relatively rare when compared to the incidence rates of other cancers. The word mesothelioma is derived from the English word mesothelium, which is

More information

Prostate Cancer. Treatments as unique as you are

Prostate Cancer. Treatments as unique as you are Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential

More information